NewLimit

Coinbase CEO’s Longevity Startup Raises $45M From Eli Lilly & Others

NewLimit, co-founded by Coinbase CEO Brian Armstrong, raised $45 million from Eli Lilly, Duke, and more to advance its anti-aging medicines.

NewLimit aging

NewLimit Raises $40M in Bid To Reverse Aging

NewLimit, a biotech company, is on a mission to reverse the features of aging by manipulating cell age without changing cell type.